|
|
View Clinical Trial (Medical Research Study)
|
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab - NCT00808210-53406 (Clinical Trial 259520)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy259520.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Racine |
|
State:
|
|
WI |
| Zip Code: |
|
53406 |
| Conditions: |
|
Rheumatoid Arthritis |
| Purpose: |
|
This is a Phase II, randomized, active-controlled, double-blind, double-dummy,
parallel-group, multicenter study in the United States enrolling patients with active RA.
The study will enroll approximately 290 patients at approximately 130 sites.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Age ≥ 18 years
- Current treatment for RA on an outpatient basis
- Active disease
- Currently receiving 50 mg etanercept subcutaneously (SC) every week or 40 mg
adalimumab SC every other week.
- Considered by Investigator to be a primary non-responder to their first anti-TNFα
treatment for efficacy reasons
Exclusion Criteria:
- Rheumatic autoimmune disease other than RA, or significant systemic involvement
secondary to RA
- History of, or current, inflammatory joint disease other than RA (e.g., gout,
reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, Lyme
disease) or other systemic autoimmune disorder (e.g., systemic lupus erythematosus,
inflammatory bowel disease, scleroderma, inflammatory myopathy, mixed connective
tissue disease or other overlap syndrome)
- Previous treatment with a any biologic therapy for RA (including investigational
products with the exception of etanercept or adalimumab
- Treatment with more than one prior anti-TNFα therapy |
|
|
|
| Study is available at: |
|
Arthritis Clinic
Racine, WI 53406
United States
Primary Contact:
Chris Birchbauer
Email: fun4birch@wi.rr.com
Phone: 262-637-1000
Secondary Contact:
Genentech Trial Information Support Line
Phone: 888-662-6728 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|